The ovarian dysgenesis syndrome

Journal of Developmental Origins of Health and Disease

Volumn 2, Issue 1, 2011, Pages 25-35

  Buck Louis, G M ^a   Cooney, M A ^a   Peterson, C M ^b  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

early origins; exposome; ovarian dysgenesis

Indexed keywords

EID: 80051548215     PISSN: 20401744     EISSN: 20401752     Source Type: Journal    
DOI: 10.1017/S2040174410000693     Document Type: Conference Paper

References (150)

1. Barker DJ. Mothers, Babies, and Disease Later in Life, 1984. BMJ Publishing Group, London.
2. Ben-Shlomo Y, Kuh D. A life course approach to chronic disease epidemiology: Conceptual models, empirical challenges and interdisciplinary perspectives. Int J Epidemiol. 2002; 31, 285-293. (Pubitemid 34537777)
3. Buck Louis GM, Cooney MA. Effects of environmental contaminants on ovarian function and fertility. In Novel Concepts in Ovarian Endocrinology (ed. Gonzalez-Bulnes A), 2007; pp. 249-268. Transworld Research Network, Kerala.
4. Gluckman PD, Hanson MA. Living with the past: Evolution, development, and patterns of disease. Science. 2004; 305, 1733-1736. (Pubitemid 39249632)
5. Heindel JJ. Role of exposure to environmental chemicals in the developmental basis of reproductive disease and dysfunction. Semin Reprod Med. 2006; 24, 168-177.
6. De Stavola BL, Nitsch D, dos SSI, et al. Statistical issues in life course epidemiology. Am J Epidemiol. 2006; 163, 84-96. (Pubitemid 43007118)
7. Carlin BP, Louis TA. Bayesian Methods for Data Analysis, 3rd edn, 2009. Chapman & Hall/CRC Press, Boca Raton, FL.
8. Lutz W, O'Neill BC, Scherbov S. Demographics. Europe's population at a turning point. Science. 2003; 299, 1991-1992.
9. Skakkebaek NE, Rajpert-De ME, Main KM. Testicular dysgenesis syndrome: An increasingly common developmental disorder with environmental aspects. Hum Reprod. 2001; 16, 972-978. (Pubitemid 32451837)
10. Andersen AG, Jensen TK, Carlsen E, et al. High frequency of sub-optimal semen quality in an unselected population of young men. Hum Reprod. 2000; 15, 366-372. (Pubitemid 30076717)
11. Carlsen E, Giwercman A, Keiding N, Skakkebaek NE. Evidence for decreasing quality of semen during past 50 years. BMJ. 1992; 305, 609-613.
12. Chilvers C, Pike MC, Forman D, Fogelman K, Wadsworth ME. Apparent doubling of frequency of undescended testis in England and Wales in 1962-81. Lancet. 1984; 2, 330-332. (Pubitemid 14054829)
13. Paulozzi LJ, Erickson JD, Jackson RJ. Hypospadias trends in two US surveillance systems. Pediatrics. 1997; 100, 831-834. (Pubitemid 27463319)
14. Moller H. Trends in sex-ratio, testicular cancer and male reproductive hazards: Are they connected? APMIS. 1998; 106, 232-238.
15. Baker JA, Buck GM, Vena JE, Moysich KB. Fertility patterns prior to testicular cancer diagnosis. Cancer Causes Control. 2005; 16, 295-299. (Pubitemid 40897848)
16. Prener A, Engholm G, Jensen OM. Genital anomalies and risk for testicular cancer in Danish men. Epidemiology. 1996; 7, 14-19. (Pubitemid 26003840)
17. Leon DA, Lithell HO, Vagero D, et al. Reduced fetal growth rate and increased risk of death from ischaemic heart disease: Cohort study of 15 000 Swedish men and women born 1915-29. BMJ. 1998; 317, 241-245. (Pubitemid 28334149)
18. Lithell HO, McKeigue PM, Berglund L, et al. Relation of size at birth to non-insulin dependent diabetes and insulin concentrations in men aged 50-60 years. BMJ. 1996; 312, 406-410. (Pubitemid 26055355)
19. McCormack VA, dos SSI, De Stavola BL, et al. Fetal growth and subsequent risk of breast cancer: Results from long term follow up of Swedish cohort. BMJ. 2003; 326, 248.
20. Barker DJ. Fetal and Infant Origins of Adult Disease, 1992. BMJ Publication, London.
21. Wilson VS, Blystone CR, Hotchkiss AK, Rider CV, Gray LE Jr. Diverse mechanisms of anti-androgen action: Impact on male rat reproductive tract development. Int J Androl. 2008; 31, 178-187.
22. Mendola P, Buck Louis GM. Environmental contaminants, female reproductive health and fertility. In Environmental Impacts on Reproductive Health and fertility (eds. Woodruff TJ, Janssen SJ, Guilette LJ, Giudice LC), 2010; pp. 161-172. Cambridge University Press, Cambridge.
23. Wood J. Dynamics of Human Reproduction: Biology, Biometry, and Demography, 1994. Aldine de Gruyter, New York.
24. Chapin RE, Robbins WA, Schieve LA, et al. Off to a good start: The influence of pre- and periconceptional exposures, parental fertility, and nutrition on children's health. Environ Health Perspect. 2004; 112, 69-78. (Pubitemid 38081517)
25. Calabrese EJ. Sex differences in susceptibility to toxic industrial chemicals. Br J Ind Med. 1986; 43, 577-579. (Pubitemid 16011537)
26. Kuh D, Ben-Shlomo Y. A Lifecourse Approach to Chronic Disease Epidemiology, 2005. Oxford University Press, Inc., New York.
27. Lucifero D, Chaillet JR, Trasler JM. Potential significance of genomic imprinting defects for reproduction and assisted reproductive technologies. Hum Reprod Update. 2004; 10, 3-18. (Pubitemid 38263159)
28. Latham KE. Epigenetic modification and imprinting of the mammalian genome during development. Curr Top Dev Biol. 1999; 43, 1-49.
29. Obata Y, Kaneko-Ishino T, Koide T, et al. Disruption of primary imprinting during oocyte growth leads to the modified expression of imprinted genes during embryogenesis. Development. 1998; 125, 1553-1560. (Pubitemid 28239365)
30. Owen CM, Segars JH. Imprinting disorders and assisted reproductive technology. Semin Reprod Med. 2009; 27, 417-428.
31. Dorais J, Peterson CM. Mullerian (Paramesonephric) Anomalies and associated Wolffian (Mesonephric) Duct malformations. In Reproductive Endocrinology and Infertility Integrating Modern Clinical and Laboratory Practice (eds. Carrell DT, Peterson CM), 2010; pp. 265-280. Springer, Philadelphia, PA.
32. Witschi E. Migration of the germ cells of human embryos from the yolk sac to the primitive gonadal folds. Contrib Embryol. 1948, 67-80.
33. Acien P, Acien M, Sanchez-Ferrer M. Complex malformations of the female genital tract. New types and revision of classification. Hum Reprod. 2004; 19, 2377-2384. (Pubitemid 39406704)
34. Hammoud AO, Gibson M, Peterson CM, et al. Quantification of the familial contribution to mullerian anomalies. Obstet Gynecol. 2008; 111(Pt 1), 378-384. (Pubitemid 351653429)
35. Gondos B, Westergaard L, Byskov AG. Initiation of oogenesis in the human fetal ovary: Ultrastructural and squash preparation study. Am J Obstet Gynecol. 1986; 155, 189-195. (Pubitemid 16100558)
36. Van SL. From epigenesis to epigenetics: The case of C. H. Waddington. Ann N Y Acad Sci. 2002; 981, 61-81.
37. Peterson CM, Carrell DT, Varner M, et al. The environment and reproduction: Endocrine disruption, reproductive impairment, and epigenetics. In Reproductive Endocrinology and Infertility Integrating Modern Clinical and Laboratory Practice (eds. Carrell DT, Peterson CM), 2010; pp. 781-803. Springer, Philadelphia, PA.
38. Hennig B, Meerarani P, Slim R, et al. Proinflammatory properties of coplanar PCBs: In vitro and in vivo evidence. Toxicol Appl Pharmacol. 2002; 181, 174-183. (Pubitemid 34757087)
39. Ivnitski-Steele ID, Sanchez A, Walker MK. 2,3,7,8- tetrachlorodibenzo-p- dioxin reduces myocardial hypoxia and vascular endothelial growth factor expression during chick embryo development. Birth Defects Res A Clin Mol Teratol. 2004; 70, 51-58. (Pubitemid 38295834)
40. Long X, Burke KA, Bigsby RM, Nephew KP. Effects of the xenoestrogen bisphenol A on expression of vascular endothelial growth factor (VEGF) in the rat. Exp Biol Med (Maywood). 2001; 226, 477-483. (Pubitemid 32506375)
41. Bredhult C, Backlin BM, Olovsson M. Effects of some endocrine disruptors on the proliferation and viability of human endometrial endothelial cells in vitro. Reprod Toxicol. 2007; 23, 550-559. (Pubitemid 46754749)
42. Muhlhauser A, Susiarjo M, Rubio C, et al. Bisphenol A effects on the growing mouse oocyte are influenced by diet. Biol Reprod. 2009; 80, 1066-1071.
43. Jirtle RL, Skinner MK. Environmental epigenomics and disease susceptibility. Nat Rev Genet. 2007; 8, 253-262. (Pubitemid 46439287)
44. Newbold RR, Hanson RB, Jefferson WN, et al. Increased tumors but uncompromised fertility in the female descendants of mice exposed developmentally to diethylstilbestrol. Carcinogenesis. 1998; 19, 1655-1663. (Pubitemid 28441870)
45. Skinner MK. Endocrine disruptors and epigenetic transgenerational disease etiology. Pediatr Res. 2007; 61(Pt 2), 48R-50R. (Pubitemid 46653068)
46. Steinberg RM, Walker DM, Juenger TE, Woller MJ, Gore AC. Effects of perinatal polychlorinated biphenyls on adult female rat reproduction: Development, reproductive physiology, and second generational effects. Biol Reprod. 2008; 78, 1091-1101. (Pubitemid 351749295)
47. Walker BE, Haven MI. Intensity of multigenerational carcinogenesis from diethylstilbestrol in mice. Carcinogenesis. 1997; 18, 791-793. (Pubitemid 28132469)
48. Buck Louis GM, Lynch CD, Cooney MA. Environmental influences on female fecundity and fertility. Semin Reprod Med. 2006; 24, 147-155.
49. McLachlan JA, Simpson E, Martin M. Endocrine disrupters and female reproductive health. Best Pract Res Clin Endocrinol Metab. 2006; 20, 63-75. (Pubitemid 43323764)
50. Mendola P, Messer LC, Rappazzo K. Science linking environmental contaminant exposures with fertility and reproductive health impacts in the adult female. Fertil Steril. 2008; 89(Suppl 2), e81-e94. (Pubitemid 351749398)
51. Miller KP, Borgeest C, Greenfeld C, Tomic D, Flaws JA. In utero effects of chemicals on reproductive tissues in females. Toxicol Appl Pharmacol. 2004; 198, 111-131. (Pubitemid 38952832)
52. Toft G, Hagmar L, Giwercman A, Bonde JP. Epidemiological evidence on reproductive effects of persistent organochlorines in humans. Reprod Toxicol. 2004; 19, 5-26. (Pubitemid 39164873)
53. Nichols HB, Trentham-Dietz A, Hampton JM, et al. From menarche to menopause: Trends among US women born from 1912-1969. Am J Epidemiol. 2006; 164, 1003-1011. (Pubitemid 44729843)
54. Karpati AM, Rubin CH, Kieszak SM, Marcus M, Troiano RP. Stature and pubertal stage assessment in American boys: The 1988-1994 Third National Health and Nutrition Examination Survey. J Adoles Health. 2002; 30, 205-212. (Pubitemid 34175146)
55. Herman-Giddens ME, Slora EJ, Wasserman RC, et al. Secondary sexual characteristics and menses in young girls seen in office practice: A study from the Pediatric Research Office Settings network. Pediatr. 1997; 99, 505-512.
56. North American Menopause Society. Menopause Core Curriculum Study Guide, 2002. North American Menopause Society, Cleveland, OH.
57. de Bruin JP, Dorland M, Bruinse HW, et al. Fetal growth retardation as a cause of impaired ovarian development. Early Hum Dev. 1998; 51, 39-46. (Pubitemid 28159567)
58. Ibanez L, Potau N, Enriquez G, de ZF. Reduced uterine and ovarian size in adolescent girls born small for gestational age. Pediatr Res. 2000; 47, 575-577. (Pubitemid 30249842)
59. Ibanez L, Potau N, Ferrer A, et al. Reduced ovulation rate in adolescent girls born small for gestational age. J Clin Endocrinol Metab. 2002; 87, 3391-3393. (Pubitemid 34816394)
60. Jensen TK, Joffe M, Scheike T, et al. Early exposure to smoking and future fecundity among Danish twins. Int J Androl. 2006; 29, 603-613. (Pubitemid 44800239)
61. Taylor KC, Jackson LW, Lynch CD, Kostyniak PJ, Buck Louis GM. Preconception maternal polychlorinated biphenyl concentrations and the secondary sex ratio. Environ Res. 2007; 103, 99-105. (Pubitemid 44920195)
62. Weisskopf MG, Anderson HA, Hanrahan LP. Decreased sex ratio following maternal exposure to polychlorinated biphenyls from contaminated Great Lakes sport-caught fish: A retrospective cohort study. Environ Health. 2003; 2, 2.
63. del Rio Gomez I Marshall T, Tsai P, Shao YS, Guo YL. Number of boys born to men exposed to polychlorinated byphenyls. Lancet. 2002; 360, 143-144. (Pubitemid 34786207)
64. Mocarelli P, Gerthoux PM, Ferrari E, et al. Paternal concentrations of dioxin and sex ratio of offspring. Lancet. 2000; 355, 1858-1863. (Pubitemid 30311877)
65. Buck Louis GM, Dmochowski J, Lynch C, et al. Polychlorinated biphenyl serum concentrations, lifestyle and time-to-pregnancy. Hum Reprod. 2009; 24, 451-458.
66. Law DC, Klebanoff MA, Brock JW, Dunson DB, Longnecker MP. Maternal serum levels of polychlorinated biphenyls and 1,1-dichloro-2,2-bis(p-chlorophenyl) ethylene (DDE) and time to pregnancy. Am J Epidemiol. 2005; 162, 523-532. (Pubitemid 41253250)
67. Eskenazi B, Warner M, Marks AR, et al. Serum dioxin concentrations and time to pregnancy. Epidemiology. 2010; 21, 224-231.
68. Harley KG, Marks AR, Chevrier J, et al. PBDE concentrations in women's serum and fecundability. Environ Health Perspect. 2010; 118, 699-704.
69. Cole DC, Wainman B, Sanin LH, et al. Environmental contaminant levels and fecundability among non-smoking couples. Reprod Toxicol. 2006; 22, 13-19. (Pubitemid 43963320)
70. Stephen EH, Chandra A. Updated projections of infertility in the United States: 1995-2025. Fertil Steril. 1998; 70, 30-34. (Pubitemid 28294617)
71. Stephen EH, Chandra A. Declining estimates of infertility in the United States: 1982-2002. Fertil Steril. 2006; 86, 516-523. (Pubitemid 44307044)
72. Daguet F. Un Siecle de Fecondite Francaise: 1901-1999, 2010. INSEE, Paris.
73. Leridon H. Can assisted reproduction technology compensate for the natural decline in fertility with age? A model assessment. Hum Reprod. 2004; 19, 1548-1553. (Pubitemid 38997179)
74. Menken J, Trussell J, Larsen U. Age and infertility. Science. 1986; 233, 1389-1394. (Pubitemid 17169372)
75. Olsen J, Rachootin P. Invited commentary: Monitoring fecundity over time - if we do it, then let's do it right. Am J Epidemiol. 2003; 157, 94-97. (Pubitemid 36077440)
76. Joffe M. Invited commentary: The potential for monitoring of fecundity and the remaining challenges. Am J Epidemiol. 2003; 157, 89-93. (Pubitemid 36077439)
77. Herbst AL, Bern HA. Developmental Effects of Diethylstilbestrol (DES) in Pregnancy, 1981. Thieme-Stratton, New York.
78. Kaufman RH, Adam E, Binder GL, Gerthoffer E. Upper genital tract changes and pregnancy outcome in offspring exposed in utero to diethylstilbestrol. Am J Obstet Gynecol. 1980; 137, 299-308. (Pubitemid 10068714)
79. Saravelos SH, Cocksedge KA, Li TC. Prevalence and diagnosis of congenital uterine anomalies in women with reproductive failure: A critical appraisal. Hum Reprod Update. 2008; 14, 415-429.
80. Dorland. Dorland's Medical Dictionary and Illustrations, 31st edn, 2007. W.B. Saunders, Philadelphia, PA.
81. Buttram VC Jr, Reiter RC. Uterine leiomyomata: Etiology, symptomatology, and management. Fertil Steril. 1981; 36, 433-445. (Pubitemid 11027013)
82. Stewart EA. Uterine fibroids. Lancet. 2001; 357, 293-298. (Pubitemid 32120866)
83. Wallach EE, Vlahos NF. Uterine myomas: An overview of development, clinical features, and management. Obstet Gynecol. 2004; 104, 393-406. (Pubitemid 40458890)
84. Viswanathan M, Hartmann K, McKoy N, et al. Management of uterine fibroids: An update of the evidence. Evid Rep Technol Assess (Full Rep). 2007, 1-122.
85. Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: Ultrasound evidence. Am J Obstet Gynecol. 2003; 188, 100-107. (Pubitemid 36135604)
86. Ishikawa H, Reierstad S, Demura M, et al. High aromatase expression in uterine leiomyoma tissues of African-American women. J Clin Endocrinol Metab. 2009; 94, 1752-1756.
87. Klatsky PC, Tran ND, Caughey AB, Fujimoto VY. Fibroids and reproductive outcomes: A systematic literature review from conception to delivery. Am J Obstet Gynecol. 2008; 198, 357-366. (Pubitemid 351451939)
88. Newbold RR, Moore AB, Dixon D. Characterization of uterine leiomyomas in CD-1 mice following developmental exposure to diethylstilbestrol (DES). Toxicol Pathol. 2002; 30, 611-616.
89. Baird DD, Newbold R. Prenatal diethylstilbestrol (DES) exposure is associated with uterine leiomyoma development. Reprod Toxicol. 2005; 20, 81-84. (Pubitemid 40459654)
90. D'Aloisio AA, Baird DD, Deroo LA, Sandler DP. Association of intrauterine and early-life exposures with diagnosis of uterine leiomyomata by 35 years of age in the sister study. Environ Health Perspect. 2010; 118, 375-381.
91. Wise LA, Palmer JR, Rowlings K, et al. Risk of benign gynecologic tumors in relation to prenatal diethylstilbestrol exposure. Obstet Gynecol. 2005; 105, 167-173. (Pubitemid 40189928)
92. Azziz R, Woods KS, Reyna R, et al. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab. 2004; 89, 2745-2749. (Pubitemid 38766360)
93. Goodarzi MO, Quinones MJ, Azziz R, et al. Polycystic ovary syndrome in Mexican-Americans: Prevalence and association with the severity of insulin resistance. Fertil Steril. 2005; 84, 766-769. (Pubitemid 41317746)
94. The Rotterdam ESHRE/ASRM-sponsored PCOS Consensus Working Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004; 19, 41-47.
95. Kumarapeli V, Seneviratne RA, Wijeyaratne CN, Yapa RM, Dodampahala SH. A simple screening approach for assessing community prevalence and phenotype of polycystic ovary syndrome in a semi-urban population in Sri Lanka. Am J Epidemiol. 2008; 168, 321-328. (Pubitemid 352019785)
96. Cresswell JL, Barker DJ, Osmond C, et al. Fetal growth, length of gestation, and polycystic ovaries in adult life. Lancet. 1997; 350, 1131-1135. (Pubitemid 27454005)
97. Wickenheisser JK, Nelson-DeGrave VL, McAllister JM. Human ovarian theca cells in culture. Trends Endocrinol Metab. 2006; 17, 65-71.
98. Abbott DH, Barnett DK, Bruns CM, Dumesic DA. Androgen excess fetal programming of female reproduction: A developmental aetiology for polycystic ovary syndrome? Hum Reprod Update. 2005; 11, 357-374.
99. Takeuchi T, Tsutsumi O, Ikezuki Y, Takai Y, Taketani Y. Positive relationship between androgen and the endocrine disruptor, bisphenol A, in normal women and women with ovarian dysfunction. Endocr J. 2004; 51, 165-169. (Pubitemid 38657551)
100. Tsutsumi O. Assessment of human contamination of estrogenic endocrine-disrupting chemicals and their risk for human reproduction. J Steroid Biochem Mol Biol. 2005; 93, 325-330. (Pubitemid 40602507)
101. Abbott DH, Dumesic DA, Franks S. Developmental origin of polycystic ovary syndrome - a hypothesis. J Endocrinol. 2002; 174, 1-5. (Pubitemid 34830927)
102. Eisner JR, Barnett MA, Dumesic DA, Abbott DH. Ovarian hyperandrogenism in adult female rhesus monkeys exposed to prenatal androgen excess. Fertil Steril. 2002; 77, 167-172. (Pubitemid 34093911)
103. Leibson CL, Good AE, Hass SL, et al. Incidence and characterization of diagnosed endometriosis in a geographically defined population. Fertil Steril. 2004; 82, 314-321. (Pubitemid 39092028)
104. Houston DE. Evidence for the risk of pelvic endometriosis by age, race and socioeconomic status. Epidemiol Rev. 1984; 6, 167-191. (Pubitemid 14024793)
105. Olive DL, Schwartz LB. Endometriosis. N Engl J Med. 1993; 328, 1759-1769.
106. Carter JE. Combined hysteroscopic and laparoscopic findings in patients with chronic pelvic pain. J Am Assoc Gynecol Laparosc. 1994; 2, 43-47.
107. Mahmood TA, Templeton A. Prevalence and genesis of endometriosis. Hum Reprod. 1991; 6, 544-549.
108. Moen MH, Muus KM. Endometriosis in pregnant and nonpregnant women at tubal sterilization. Hum Reprod. 1991; 6, 699-702.
109. Strathy JH, Molgaard CA, Coulam CB, Melton III LJ. Endometriosis and infertility: A laparoscopic study of endometriosis among fertile and infertile women. Fertil Steril. 1982; 38, 667-672. (Pubitemid 13198264)
110. Wardle PG, Hull MG. Is endometriosis a disease? Baillieres Clin Obstet Gynaecol. 1993; 7, 673-685. (Pubitemid 24032860)
111. Rier SE, Martin DC, Bowman RE, Dmowski WP, Becker JL. Endometriosis in rhesus monkeys (Macaca mulatta) following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Fundam Appl Toxicol. 1993; 21, 433-441. (Pubitemid 23338558)
112. Rier SE, Turner WE, Martin DC, et al. Serum levels of TCDD and dioxin-like chemicals in Rhesus monkeys chronically exposed to dioxin: Correlation of increased serum PCB levels with endometriosis. Toxicol Sci. 2001; 59, 147-159. (Pubitemid 32117991)
113. Heilier JF, Nackers F, Verougstraete V, et al. Increased dioxinlike compounds in the serum of women with peritoneal endometriosis and deep endometriotic (adenomyotic) nodules. Fertil Steril. 2005; 84, 305-312. (Pubitemid 41125249)
114. Mayani A, Barel S, Soback S, Almagor M. Dioxin concentrations in women with endometriosis. Hum Reprod. 1997; 12, 373-375. (Pubitemid 27129404)
115. Jackson LW, Zullo MD, Goldberg JM. The association between heavy metals, endometriosis and uterine myomas among premenopausal women: National Health and Nutrition Examination Survey 1999-2002. Hum Reprod. 2008; 23, 679-687. (Pubitemid 351651206)
116. Cobellis L, Latini G, De FC, et al. High plasma concentrations of di-(2-ethylhexyl)-phthalate in women with endometriosis. Hum Reprod. 2003; 18, 1512-1515. (Pubitemid 36840962)
117. Reddy BS, Rozati R, Reddy S, et al. High plasma concentrations of polychlorinated biphenyls and phthalate esters in women with endometriosis: A prospective case control study. Fertil Steril. 2006; 85, 775-779. (Pubitemid 43261586)
118. Gerhard I, Runnebaum B. The limits of hormone substitution in pollutant exposure and fertility disorders. Zentralbl Gynakol. 1992; 114, 593-602. (Pubitemid 23008786)
119. Louis GM, Weiner JM, Whitcomb BW, et al. Environmental PCB exposure and risk of endometriosis. Hum Reprod. 2005; 20, 279-285.
120. Porpora MG, Ingelido AM, di DA, et al. Increased levels of polychlorobiphenyls in Italian women with endometriosis. Chemosphere. 2006; 63, 1361-1367.
121. Quaranta MG, Porpora MG, Mattioli B, et al. Impaired NK-cell-mediated cytotoxic activity and cytokine production in patients with endometriosis: A possible role for PCBs and DDE. Life Sci. 2006; 79, 491-498. (Pubitemid 43866128)
122. Richardson DB, Ciampi A. Effects of exposure measurement error when an exposure variable is constrained by a lower limit. Am J Epidemiol. 2003; 157, 355-363. (Pubitemid 36193938)
123. Schisterman EF, Whitcomb BW, Louis GM, Louis TA. Lipid adjustment in the analysis of environmental contaminants and human health risks. Environ Health Perspect. 2005; 113, 853-857. (Pubitemid 40984184)
124. Schisterman EF, Vexler A, Whitcomb BW, Liu A. The limitations due to exposure detection limits for regression models. Am J Epidemiol. 2006; 163, 374-383. (Pubitemid 43238432)
125. Missmer SA, Hankinson SE, Spiegelman D, et al. In utero exposures and the incidence of endometriosis. Fertil Steril. 2004; 82, 1501-1508. (Pubitemid 39611373)
126. Hediger ML, Hartnett HJ, Louis GM. Association of endometriosis with body size and figure. Fertil Steril. 2005; 84, 1366-1374. (Pubitemid 41571883)
127. Vitonis AF, Baer HJ, Hankinson SE, Laufer MR, Missmer SA. A prospective study of body size during childhood and early adulthood and the incidence of endometriosis. Hum Reprod. 2010; 25, 1325-1334.
128. Buck Louis GM, Hediger ML, Pena JB. Intrauterine exposures and risk of endometriosis. Hum Reprod. 2007; 22, 3232-3236. (Pubitemid 351696796)
129. Colditz GA, Sellers TA, Trapido E. Epidemiology - identifying the causes and preventability of cancer? Nat Rev Cancer. 2006; 6, 75-83. (Pubitemid 43053653)
130. Garcia M, Jemal A, Ward EM, et al. Global Cancer Facts and Figures 2007, 2007. American Cancer Society, Atlanta, GA.
131. Fast Stats: An interactive tool for access to SEER cancer statistics. Surveillance Reserach Program, National Cancer Institute. Retrieved 20 December 2010 from http://seer.cancer.gov/faststats.
132. Cossu A, Budroni M, Capobianco G, et al. Epidemiological aspects of ovarian malignancies in North Sardinia in the period 1992-2001. Eur J Gynaecol Oncol. 2005; 26, 47-50. (Pubitemid 40314067)
133. Mok SC, Kwong J, Welch WR, et al. Etiology and pathogenesis of epithelial ovarian cancer. Dis Markers. 2007; 23, 367-376. (Pubitemid 350171265)
134. Grammatikakis I, Zervoudis S, Evangelinakis N, Tziortzioti V. Endometrium and ovarian cancer synchronous to endometriosis - a retrospective study of our experience of 7 years. J Med Life. 2010; 3, 76-79.
135. Ahlborg UG, Lipworth L, Titus-Ernstoff L, et al. Organochlorine compounds in relation to breast cancer, endometrial cancer, and endometriosis: An assessment of the biological and epidemiological evidence. Crit Rev Toxicol. 1995; 25, 463-531. (Pubitemid 26007610)
136. Sturgeon SR, Brock JW, Potischman N, et al. Serum concentrations of organochlorine compounds and endometrial cancer risk (United States). Cancer Causes Control. 1998; 9, 417-424. (Pubitemid 28466694)
137. Weiderpass E, Adami HO, Baron JA, et al. Organochlorines and endometrial cancer risk. Cancer Epidemiol Biomarkers Prev. 2000; 9, 487-493. (Pubitemid 30313891)
138. Crain DA, Janssen SJ, Edwards TM, et al. Female reproductive disorders: The roles of endocrine-disrupting compounds and developmental timing. Fertil Steril. 2008; 90, 911-940.
139. Palmer JR, Wise LA, Hatch EE, et al. Prenatal diethylstilbestrol exposure and risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2006; 15, 1509-1514. (Pubitemid 44299324)
140. Xue F, Michels KB. Intrauterine factors and risk of breast cancer: A systematic review and meta-analysis of current evidence. Lancet Oncol. 2007; 8, 1088-1100. (Pubitemid 350192898)
141. Strohsnitter WC, Noller KL, Titus-Ernstoff L, et al. Breast cancer incidence in women prenatally exposed to maternal cigarette smoke. Epidemiology. 2005; 16, 342-345. (Pubitemid 40586709)
142. Somigliana E, Vercellini P, Daguati R, et al. Fibroids and female reproduction: A critical analysis of the evidence. Hum Reprod Update. 2007; 13, 465-476. (Pubitemid 47299852)
143. Boomsma CM, Eijkemans MJ, Hughes EG, et al. A metaanalysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod Update. 2006; 12, 673-683. (Pubitemid 44605508)
144. Brosens IA, De SP, Hamerlynck T, et al. Endometriosis is associated with a decreased risk of pre-eclampsia. Hum Reprod. 2007; 22, 1725-1729. (Pubitemid 47055165)
145. Sinaii N, Cleary SD, Ballweg ML, Nieman LK, Stratton P. High rates of autoimmune and endocrine disorders, fibromyalgia, chronic fatigue syndrome and atopic diseases among women with endometriosis: A survey analysis. Hum Reprod. 2002; 17, 2715-2724. (Pubitemid 35174127)
146. Kobayashi H, Sumimoto K, Moniwa N, et al. Risk of developing ovarian cancer among women with ovarian endometrioma: A cohort study in Shizuoka, Japan. Int J Gynecol Cancer. 2007; 17, 37-43. (Pubitemid 46213967)
147. Brinton LA, Gridley G, Persson I, Baron J, Bergqvist A. Cancer risk after a hospital discharge diagnosis of endometriosis. Am J Obstet Gynecol. 1997; 176, 572-579. (Pubitemid 27147164)
148. Ogawa S, Kaku T, Amada S, et al. Ovarian endometriosis associated with ovarian carcinoma: A clinicopathological and immunohistochemical study. Gynecol Oncol. 2000; 77, 298-304. (Pubitemid 30317153)
149. Yoshikawa H, Jimbo H, Okada S, et al. Prevalence of endometriosis in ovarian cancer. Gynecol Obstet Invest. 2000; 50(Suppl 1), 11-17.
150. Wild CP. Complementing the genome with an 'exposome': The outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiol Biomarkers Prev. 2005; 14, 1847-1850. (Pubitemid 41161186)